Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Hamadani

Showing results (101-110 of 460) with videos related to

Pageof 46
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2019
FLT3 Inhibitor Maintenance After Allogeneic Transplantation: Is a Placebo-Controlled, Randomized Trial Ethical?Mark J Levis, Yi-Bin Chen, Mehdi Hamadani, et al.
International Journal of Antimicrobial Agents|October 17, 2012
Evaluation of an alternative posaconazole prophylaxis regimen in haematological malignancy patients receiving concomitant stress ulcer prophylaxisAshley L Ross, Douglas Slain, Aaron Cumpston, et al.
Blood|August 2, 2021
Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapyBinod Dhakal, Sameem Abedin, Timothy Fenske, et al.
Transplantation and Cellular Therapy|May 9, 2021
Cellular Therapies for Mantle Cell LymphomaFarah Yassine, Jose Sandoval-Sus, Ernesto Ayala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 27, 2013
Monoclonal antibodies in conditioning regimens for hematopoietic cell transplantationMohamed A Kharfan-Dabaja, Taiga Nishihori, Zaher K Otrock, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 4, 2016
Impact of intravenous magnesium infusion rate during ambulatory replacements on serum magnesium concentrations after allogeneic stem cell transplantMatthew Snyder, Alexandra Shillingburg, Michael Newton, et al.
Cancer|August 24, 2019
Upfront autologous hematopoietic stem cell transplantation consolidation for patients with aggressive B-cell lymphomas in first remission in the rituximab era: A systematic review and meta-analysisNarendranath Epperla, Mehdi Hamadani, Tea Reljic, et al.
Hematological Oncology|October 3, 2022
Autologous hematopoietic cell transplantation versus whole-brain radiotherapy consolidation in primary central nervous system lymphoma: A systematic review and meta-analysisNarendranath Epperla, Tea Reljic, Sayan Mullick Chowdhury, et al.
Bone Marrow Transplantation|December 15, 2023
Therapeutic options for large B-cell lymphoma relapsing after CD19-directed CAR T-cell therapySamantha El Warrak, Mohamed A Kharfan-Dabaja, Madiha Iqbal, et al.
Cancer Chemotherapy and Pharmacology|November 5, 2022
Exposure-response analysis of Camidanlumab tesirine in patients with relapsed or refractory classical Hodgkin lymphoma and non-Hodgkin lymphomaMarie Toukam, Joseph P Boni, Mehdi Hamadani, et al.
Pageof 46

Showing results (101-110 of 460) with videos related to

Sort By:
Pageof 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2019
FLT3 Inhibitor Maintenance After Allogeneic Transplantation: Is a Placebo-Controlled, Randomized Trial Ethical?Mark J Levis, Yi-Bin Chen, Mehdi Hamadani, et al.
International Journal of Antimicrobial Agents|October 17, 2012
Evaluation of an alternative posaconazole prophylaxis regimen in haematological malignancy patients receiving concomitant stress ulcer prophylaxisAshley L Ross, Douglas Slain, Aaron Cumpston, et al.
Blood|August 2, 2021
Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapyBinod Dhakal, Sameem Abedin, Timothy Fenske, et al.
Transplantation and Cellular Therapy|May 9, 2021
Cellular Therapies for Mantle Cell LymphomaFarah Yassine, Jose Sandoval-Sus, Ernesto Ayala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 27, 2013
Monoclonal antibodies in conditioning regimens for hematopoietic cell transplantationMohamed A Kharfan-Dabaja, Taiga Nishihori, Zaher K Otrock, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 4, 2016
Impact of intravenous magnesium infusion rate during ambulatory replacements on serum magnesium concentrations after allogeneic stem cell transplantMatthew Snyder, Alexandra Shillingburg, Michael Newton, et al.
Cancer|August 24, 2019
Upfront autologous hematopoietic stem cell transplantation consolidation for patients with aggressive B-cell lymphomas in first remission in the rituximab era: A systematic review and meta-analysisNarendranath Epperla, Mehdi Hamadani, Tea Reljic, et al.
Hematological Oncology|October 3, 2022
Autologous hematopoietic cell transplantation versus whole-brain radiotherapy consolidation in primary central nervous system lymphoma: A systematic review and meta-analysisNarendranath Epperla, Tea Reljic, Sayan Mullick Chowdhury, et al.
Bone Marrow Transplantation|December 15, 2023
Therapeutic options for large B-cell lymphoma relapsing after CD19-directed CAR T-cell therapySamantha El Warrak, Mohamed A Kharfan-Dabaja, Madiha Iqbal, et al.
Cancer Chemotherapy and Pharmacology|November 5, 2022
Exposure-response analysis of Camidanlumab tesirine in patients with relapsed or refractory classical Hodgkin lymphoma and non-Hodgkin lymphomaMarie Toukam, Joseph P Boni, Mehdi Hamadani, et al.
Pageof 46